24th March 2020
Latest news
Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.
20th March 2020
A message from Curium on COVID-19 and our actions
12th March 2020
RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA
3rd March 2020
Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio
30th January 2020
Curium is attending these global congresses in 2020
7th January 2020
RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application
2nd December 2019
Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy
16th November 2019
CEO Today Healthcare Awards Winner 2019
13th November 2019
Curium Announces Plan to Submit an Application to Market Generic Ioflupane I 123 Injection in the U.S.
4th September 2019
Curium Announces Revised Pricing for Technescan MAG3TM (kit for the preparation of technetium Tc 99m mertiatide)
22nd February 2019
Curium is attending these global congresses in 2019
13th February 2019
Campaign to Support FDA Approved Products
5th February 2019
Curium Petten and NRG Agreement
9th January 2019
RadioMedix and Curium Announce FDA Fast Track Designation For 64Cu-Dotatate.
3rd January 2019
Curium and Progenics Announce European Collaboration for Prostate Cancer Imaging Agent PyL™
6th September 2018
Curium’s Renaud Dehareng recognized with CEO Healthcare Award 2018
27th August 2018
Curium and RadioMedix Announce Exclusive Global Agreement for 64Cu-Dotatate Development
10th May 2018
Curium Expands Nuclear Medicine Offerings, Announces U.S. Availability of Xenon Xe 133 Gas
2nd May 2018
Curium enhances its position in the French PET market with the completion of the acquisition of Cyclopharma’s French commercial and manufacturing operations
11th April 2018